{"count":221304,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1872","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1870","results":[{"created":"2020-04-10T18:13:57.094056+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2093","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: IL21 were set to ","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:13:43.250626+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2092","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: IL21 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:13:21.323084+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2091","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IL21 as Red List (low evidence)","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:13:21.310045+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2091","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: il21 has been classified as Red List (Low Evidence).","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:13:14.570986+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.112","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: IL21 were set to ","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:13:01.605086+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2090","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: IL21: Rating: RED; Mode of pathogenicity: None; Publications: 24746753; Phenotypes: Immunodeficiency, common variable, 11, MIM# 615767; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:12:50.960366+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.111","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: IL21 was changed from Unknown to Unknown","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:12:13.456919+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.110","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IL21 as Red List (low evidence)","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:12:13.447758+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.110","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: il21 has been classified as Red List (Low Evidence).","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:11:41.893949+10:00","panel_name":"Combined Immunodeficiency","panel_id":223,"panel_version":"0.109","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: IL21: Rating: RED; Mode of pathogenicity: None; Publications: 24746753; Phenotypes: Immunodeficiency, common variable, 11, MIM# 615767; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"IL21","entity_type":"gene"},{"created":"2020-04-10T18:07:21.503607+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2090","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: IL17F as ready","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:07:21.494694+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2090","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: il17f has been classified as Red List (Low Evidence).","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:07:10.482163+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2090","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: IL17F were changed from  to Candidiasis, familial, 6, autosomal dominant, MIM# 613956","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:06:49.783175+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2089","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: IL17F were set to ","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:06:28.006616+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2088","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: IL17F was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:06:08.609456+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2087","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IL17F as Red List (low evidence)","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:06:08.600294+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2087","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: il17f has been classified as Red List (Low Evidence).","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:05:48.646102+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2086","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: IL17F: Rating: RED; Mode of pathogenicity: None; Publications: 21350122; Phenotypes: Candidiasis, familial, 6, autosomal dominant, MIM# 613956; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:03:20.936039+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.29","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: IL17F were changed from  to Candidiasis, familial, 6, autosomal dominant, MIM# 613956","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:02:55.511986+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.28","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: IL17F were set to ","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:02:31.850221+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: IL17F was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:02:07.904011+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: IL17F as Red List (low evidence)","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T18:02:07.894690+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: il17f has been classified as Red List (Low Evidence).","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T17:59:59.784157+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: IL17F: Rating: RED; Mode of pathogenicity: None; Publications: 21350122; Phenotypes: Candidiasis, familial, 6, autosomal dominant, MIM# 613956; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"IL17F","entity_type":"gene"},{"created":"2020-04-10T17:35:05.112175+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FPR1 as ready","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:35:05.102588+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fpr1 has been classified as Red List (Low Evidence).","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:35:02.719514+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FPR1 were changed from  to Periodontitis","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:34:39.687950+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.34","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FPR1 were set to ","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:34:15.189235+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FPR1 as Red List (low evidence)","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:34:15.176474+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.33","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fpr1 has been classified as Red List (Low Evidence).","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:33:37.356408+10:00","panel_name":"Phagocyte Defects","panel_id":233,"panel_version":"0.32","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FPR1: Rating: RED; Mode of pathogenicity: None; Publications: 29105764, 28371599; Phenotypes: Periodontitis; Mode of inheritance: None","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:32:56.305750+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2086","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FPR1 as ready","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:32:56.297032+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2086","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fpr1 has been classified as Red List (Low Evidence).","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:32:48.784168+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2086","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FPR1 were changed from  to Periodontitis","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:32:28.530744+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2085","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FPR1 were set to ","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:32:14.396657+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2084","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FPR1 as Red List (low evidence)","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:32:14.387788+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2084","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fpr1 has been classified as Red List (Low Evidence).","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:31:55.021899+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2083","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FPR1: Rating: RED; Mode of pathogenicity: None; Publications: 29105764, 28371599; Phenotypes: Periodontitis; Mode of inheritance: None","entity_name":"FPR1","entity_type":"gene"},{"created":"2020-04-10T17:22:11.649059+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2083","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FCN3 as ready","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:22:11.636271+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2083","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcn3 has been classified as Amber List (Moderate Evidence).","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:22:04.060708+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2083","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FCN3 were changed from  to Immunodeficiency due to ficolin 3 deficiency, MIM# 613860","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:21:48.830776+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2082","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FCN3 were set to ","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:21:34.389981+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2081","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FCN3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:21:20.714701+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2080","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FCN3 as Amber List (moderate evidence)","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:21:20.701496+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2080","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcn3 has been classified as Amber List (Moderate Evidence).","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:21:01.987010+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2079","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FCN3: Rating: AMBER; Mode of pathogenicity: None; Publications: 25662573, 22226667, 19535802, 20971976; Phenotypes: Immunodeficiency due to ficolin 3 deficiency, MIM# 613860; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:19:39.840202+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FCN3 as ready","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:19:39.824589+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcn3 has been classified as Amber List (Moderate Evidence).","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:19:37.281042+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FCN3 were changed from  to Immunodeficiency due to ficolin 3 deficiency, MIM# 613860","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:19:14.057090+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FCN3 were set to ","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:18:49.428379+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FCN3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:18:25.819464+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FCN3 as Amber List (moderate evidence)","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:18:25.811552+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcn3 has been classified as Amber List (Moderate Evidence).","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:17:54.404321+10:00","panel_name":"Complement Deficiencies","panel_id":224,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FCN3: Rating: AMBER; Mode of pathogenicity: None; Publications: 25662573, 22226667, 19535802, 20971976; Phenotypes: Immunodeficiency due to ficolin 3 deficiency, MIM# 613860; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCN3","entity_type":"gene"},{"created":"2020-04-10T17:10:14.868432+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2079","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FCGR3A as ready","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:10:14.855084+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2079","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcgr3a has been classified as Amber List (Moderate Evidence).","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:10:05.417188+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2079","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FCGR3A were changed from  to Immunodeficiency 20, MIM# 615707","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:09:46.347633+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2078","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FCGR3A were set to ","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:09:26.916649+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2077","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FCGR3A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:09:08.439290+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2076","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FCGR3A as Amber List (moderate evidence)","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:09:08.425128+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2076","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcgr3a has been classified as Amber List (Moderate Evidence).","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:08:39.652584+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2075","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FCGR3A: Rating: AMBER; Mode of pathogenicity: None; Publications: 8874200, 23006327, 8608639; Phenotypes: Immunodeficiency 20, MIM# 615707; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:07:55.483515+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FCGR3A as ready","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:07:55.475223+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcgr3a has been classified as Amber List (Moderate Evidence).","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:07:52.110776+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FCGR3A were changed from  to Immunodeficiency 20, MIM# 615707","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:07:28.230303+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FCGR3A were set to ","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:06:58.278494+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FCGR3A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:06:34.589782+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FCGR3A as Amber List (moderate evidence)","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:06:34.576647+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcgr3a has been classified as Amber List (Moderate Evidence).","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:03:59.557908+10:00","panel_name":"Susceptibility to Viral Infections","panel_id":237,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FCGR3A: Rating: AMBER; Mode of pathogenicity: None; Publications: 8874200, 23006327, 8608639; Phenotypes: Immunodeficiency 20, MIM# 615707; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:03:08.710034+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FCGR3A as ready","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:03:08.696584+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcgr3a has been classified as Amber List (Moderate Evidence).","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:03:06.339319+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FCGR3A were changed from  to Immunodeficiency 20, MIM# 615707","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:02:39.615761+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FCGR3A were set to ","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:02:09.346468+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.23","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FCGR3A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:01:23.424928+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FCGR3A as Amber List (moderate evidence)","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T17:01:23.415678+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.22","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fcgr3a has been classified as Amber List (Moderate Evidence).","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T16:53:23.810763+10:00","panel_name":"Defects of innate immunity","panel_id":231,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FCGR3A: Rating: AMBER; Mode of pathogenicity: None; Publications: 8874200, 23006327, 8608639; Phenotypes: Immunodeficiency 20, MIM# 615707; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"FCGR3A","entity_type":"gene"},{"created":"2020-04-10T16:34:51.578247+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EPCAM as ready","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-04-10T16:34:51.569095+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: epcam has been classified as Amber List (Moderate Evidence).","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-04-10T16:34:45.501008+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.21","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EPCAM were changed from  to Diarrhea 5, with tufting enteropathy, congenital, MIM# 613217","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-04-10T16:34:19.304432+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.20","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: EPCAM were set to ","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-04-10T16:33:54.701242+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.19","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EPCAM was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-04-10T16:33:31.375481+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EPCAM as Amber List (moderate evidence)","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-04-10T16:33:31.362657+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.18","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: epcam has been classified as Amber List (Moderate Evidence).","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-04-10T16:33:02.437891+10:00","panel_name":"Inflammatory bowel disease","panel_id":123,"panel_version":"0.17","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EPCAM: Rating: AMBER; Mode of pathogenicity: None; Publications: 27302973; Phenotypes: Diarrhea 5, with tufting enteropathy, congenital, MIM# 613217; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EPCAM","entity_type":"gene"},{"created":"2020-04-10T16:07:33.683104+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CR2 as ready","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:07:33.673962+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cr2 has been classified as Amber List (Moderate Evidence).","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:07:30.625956+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.39","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CR2 were changed from  to Immunodeficiency, common variable, 7, MIM# 614699","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:06:58.819111+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.38","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CR2 were set to ","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:06:34.850545+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.37","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CR2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:06:10.969371+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CR2 as Amber List (moderate evidence)","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:06:10.949083+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.36","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cr2 has been classified as Amber List (Moderate Evidence).","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:05:40.534992+10:00","panel_name":"Predominantly Antibody Deficiency","panel_id":222,"panel_version":"0.35","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: CR2: Rating: AMBER; Mode of pathogenicity: None; Publications: 22035880, 26325596; Phenotypes: Immunodeficiency, common variable, 7, MIM# 614699; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:04:59.910015+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2075","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CR2 as ready","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:04:59.901137+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2075","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: cr2 has been classified as Amber List (Moderate Evidence).","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:04:51.580204+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2075","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: CR2 were set to ","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:04:21.907956+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2074","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: CR2 were changed from  to Immunodeficiency, common variable, 7, MIM# 614699","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:03:59.031588+10:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"0.2073","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: CR2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"CR2","entity_type":"gene"},{"created":"2020-04-10T16:03:55.278487+10:00","panel_name":"Dilated Cardiomyopathy","panel_id":95,"panel_version":"0.25","user_name":"Crystle Lee","item_type":"entity","text":"reviewed gene: DMD: Rating: GREEN; Mode of pathogenicity: None; Publications: 26066469; Phenotypes: Cardiomyopathy, dilated, 3B (MIM#302045); Mode of inheritance: X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)","entity_name":"DMD","entity_type":"gene"}]}